Metronomic therapy using Methotrexate and Celecoxib: A Boon for Oral Cancer patients during COVID-19 Pandemic.

Imaduddin, Mohammed; Sultania, Mahesh; Vigneshwaran, B; Muduly, Dillip Kumar; Kar, Madhabananda

Imaduddin, Mohammed; Sultania, Mahesh; Vigneshwaran, B; Muduly, Dillip Kumar; Kar, Madhabananda.

Imaduddin M; Department of Surgical Oncology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Sultania M; Department of Surgical Oncology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India. Electronic address: drmaheshsultania@gmail.com.
Vigneshwaran B; Department of Surgical Oncology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Muduly DK; Department of Surgical Oncology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Kar M; Department of Surgical Oncology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.

Oral Oncol ; 114: 105069, 2021 03.

Article in English | MEDLINE | ID: covidwho-933395

Subject(s)

COVID-19; Carcinoma; Mouth Neoplasms; Celecoxib; Cisplatin; Humans; Methotrexate; Mouth Neoplasms/drug therapy; Neoplasm Recurrence, Local; Pandemics; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mouth Neoplasms / Carcinoma / COVID-19 Limits: Humans Language: English Journal: Oral Oncol Journal subject: Neoplasms Year: 2021 Document Type: Article Affiliation country: J.oraloncology.2020.105069

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google